Medicare Enrolled
Dr. Brent Reed, M.D.
Family Medicine · Sugar Land, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reed
Dr. Brent Reed is a family medicine specialist in Sugar Land, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Reed performed 1,188 Medicare services across 1,033 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reed received a total of $8,065 from 50 pharmaceutical and/or device companies across 536 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reed is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 24% volume in TX
$8,065 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,188
Medicare services
Top 24% in TX for family medicine
1,033
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~85 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
140 | $87 | $292 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
130 | $10 | $31 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
116 | $13 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
112 | $60 | $206 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
85 | $123 | $298 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
70 | $10 | $25 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
47 | $16 | $50 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
42 | $8 | $20 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
39 | $19 | $40 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
37 | $66 | $188 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
36 | $31 | $50 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
35 | $283 | $450 |
| PSA test (prostate cancer screening) | 31 | $18 | $40 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
25 | $9 | $20 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
25 | $17 | $35 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
24 | $66 | $122 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
24 | $31 | $50 |
| Annual depression screening | 24 | $18 | $43 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
23 | $29 | $60 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
21 | $10 | $32 |
| Annual alcohol misuse screening, 5 to 15 minutes | 20 | $18 | $43 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
15 | $6 | $12 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
15 | $5 | $11 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
14 | $9 | $34 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
13 | $2 | $5 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $32 | $128 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
12 | $157 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,065
Total received (2018-2024)
Avg $1,152/year across 7 years
Top 7% in TX for family medicine
50
Companies
536
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,065 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$771
2023
$1,276
2022
$1,189
2021
$585
2020
$336
2019
$1,596
2018
$2,312
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$952
Abbott Laboratories
$696
AstraZeneca Pharmaceuticals LP
$670
PFIZER INC.
$592
Lilly USA, LLC
$437
Astellas Pharma US Inc
$434
Merck Sharp & Dohme Corporation
$408
Janssen Pharmaceuticals, Inc
$389
GlaxoSmithKline, LLC.
$379
Boehringer Ingelheim Pharmaceuticals, Inc.
$336
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$322
SANOFI-AVENTIS U.S. LLC
$234
Amgen Inc.
$160
Amarin Pharma Inc.
$142
Bayer HealthCare Pharmaceuticals Inc.
$135
Bayer Healthcare Pharmaceuticals Inc.
$121
AbbVie, Inc.
$119
Merck Sharp & Dohme LLC
$107
Biohaven Pharmaceutical Holding Company Ltd.
$101
AbbVie Inc.
$88
Mylan Specialty L.P.
$82
Novartis Pharmaceuticals Corporation
$75
Exact Sciences Corporation
$74
Allergan, Inc.
$74
ABBVIE INC.
$72
Teva Pharmaceuticals USA, Inc.
$71
Sumitomo Pharma America, Inc.
$70
Phathom Pharmaceuticals, Inc.
$70
Biohaven Pharmaceuticals, Inc.
$67
Takeda Pharmaceuticals U.S.A., Inc.
$60
CeQur Corporation
$52
Dexcom, Inc.
$48
Bausch Health US, LLC
$46
Sunovion Pharmaceuticals Inc.
$41
Noden Pharma USA Inc
$40
OptiNose US, Inc.
$37
Azurity Pharmaceuticals, Inc.
$33
Genentech USA, Inc.
$31
Edwards Lifesciences Corporation
$28
Shield Therapeutics Inc
$21
Nestle HealthCare Nutrition Inc.
$20
Daiichi Sankyo Inc.
$20
Shire North American Group Inc
$16
Ascensia Diabetes Care Us Inc.
$15
SI-BONE, Inc.
$14
Neurocrine Biosciences, Inc.
$14
Neos Therapeutics, LP
$14
IBSA Pharma Inc.
$13
Horizon Pharma plc
$12
Kowa Pharmaceuticals America, Inc.
$11
Top 3 companies account for 28.7% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADVAIR · AIMOVIG · AIRSUPRA · AJOVY · ANORO · APLENZIN · Adzenys XR-ODT · Aimovig · BAQSIMI · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CYCLOSET · CeQur Simplicity · Cologuard Collection Kit · DUEXIS · Dexcom G6 Transmitter · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GEMTESA · HORIZANT · Horizant · Humira · INGREZZA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NURTEC ODT · Otezla · Ozempic · PNEUMOVAX 23 · PRALUENT · PREMARIN · PREMARIN ORALS · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Proclaim Family of SCS IPGs · Prolia · QULIPTA · ROTATEQ · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · SYMBICORT · Saxenda · Synthroid · TEKTURNA · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · TZIELD · Tirosint · Tresiba · Trintellix · UBRELVY · Utibron · VESICARE · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · WELLBUTRIN XL · Wegovy · XARELTO · XIFAXAN · XIFIXAN · Xhance · Xofluza · YUPELRI · Yupelri · ZENPEP · ZOSTAVAX · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for family medicine in TX.
Equivalent to $679 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
1,412
Per 100K population
164.2
County median income
$113,409
Nearest hospital
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Reed is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), with low-engagement industry engagement in the top 7% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Reed experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Reed performed 140 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reed receive payments from pharmaceutical companies?
Yes. Dr. Reed received a total of $8,065 from 50 companies across 536 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reed's costs compare to other family medicine physicians in Sugar Land?
Dr. Reed's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Sugar Land
Browse family medicine physicians in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology